Sale disclosed
Steven Leonard Chapman
CEO AND PRESIDENT
Common Stock
- Reported value
- $526.14K
- Reported price
- $413.31 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Natera, Inc.
Last 30 daysNo qualifying insider buying. Sales: $63.19M by 4 insiders.
Showing the first 6 of 310 trades on this page.
CEO AND PRESIDENT
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
CEO AND PRESIDENT
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
Director
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
Director
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
CEO AND PRESIDENT
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CHIEF FINANCIAL OFFICER
Common Stock
CEO AND PRESIDENT
Common Stock
CEO AND PRESIDENT
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
PRESIDENT, CHIEF BUS. OFFICER
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
SEC. AND CHIEF LEGAL OFFICER
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
PRESIDENT, CLINICALDIAGNOSTICS
Common Stock
EXECUTIVE CHAIRMAN
Common Stock
EXECUTIVE CHAIRMAN
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CEO AND PRESIDENT | Common StockSale10b5-1 | 1,273$413.31 / share | $526.14K | Oct 1Filed Oct 2 · 1d later | SEC filing |
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-13 trades | 3,000avg $414.22 / share | $1.24M | Oct 1Filed Oct 2 · 1d later | 3 filings
|
| Director | Common StockSale10b5-112 trades | 18,064avg $388.01 / share | $7.01M | Sep 23Filed Sep 25 · 2d later | 12 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockGift | 945Gift · no purchase price | Not a purchase | Sep 16Filed Sep 18 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 6,000$350.07 / share | $2.1M | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Common StockSale10b5-16 trades | 3,150avg $354.19 / share | $1.12M | Sep 16Filed Sep 17 · 1d later | 6 filings
|
| EXECUTIVE CHAIRMAN | Common StockSale10b5-115 trades | 50,000avg $334.76 / share | $16.74M | Sep 14Filed Sep 16 · 2d later | 15 filings
|
| EXECUTIVE CHAIRMAN | Common StockSale10b5-114 trades | 52,000avg $347.29 / share | $18.06M | Sep 15Filed Sep 16 · 1d later | 14 filings
|
| EXECUTIVE CHAIRMAN | Common StockSale10b5-16 trades | 50,000avg $327.97 / share | $16.4M | Sep 11Filed Sep 11 · 0d later | 6 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-13 trades | 3,000avg $320.73 / share | $962.19K | Sep 1Filed Sep 3 · 2d later | 3 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-1 | 15,160$326.89 / share | $4.96M | Sep 2Filed Sep 3 · 1d later | SEC filing |
| CEO AND PRESIDENT | Common StockSale10b5-1 | 1,698$320.99 / share | $545.04K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| PRESIDENT, CHIEF BUS. OFFICER | Common StockGrant or award10b5-1 | 20,000Award · no purchase price | Non-cash award | Aug 6Filed Aug 28 · 22d later | SEC filing |
| PRESIDENT, CHIEF BUS. OFFICER | Common StockSale10b5-1 | 6,517$321.53 / share | $2.1M | Aug 10Filed Aug 28 · 18d later | SEC filing |
| Director | Common StockSale10b5-1 | 6,000$325.32 / share | $1.95M | Aug 10Filed Aug 14 · 4d later | SEC filing |
| EXECUTIVE CHAIRMAN | Common StockSale10b5-1 | 2,000$320.90 / share | $641.8K | Aug 7Filed Aug 7 · 0d later | SEC filing |
| Director | Common StockSale10b5-110 trades | 9,150avg $315.66 / share | $2.89M | Aug 7Filed Aug 7 · 0d later | 10 filings
|
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 317$267.99 / share | $84.95K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 478$274.22 / share | $131.08K | Aug 4Filed Aug 5 · 1d later | SEC filing |
| CEO AND PRESIDENT | Common StockSale10b5-17 trades | 3,076avg $266.40 / share | $819.43K | Aug 3Filed Aug 5 · 2d later | 7 filings
|
| PRESIDENT, CHIEF BUS. OFFICER | Common StockSale10b5-1 | 295$267.99 / share | $79.06K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-17 trades | 3,410avg $265.58 / share | $905.63K | Aug 3Filed Aug 5 · 2d later | 7 filings
|
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-1 | 334$267.99 / share | $89.51K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| EXECUTIVE CHAIRMAN | Common StockSale10b5-1 | 731$267.99 / share | $195.9K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 109$267.99 / share | $29.21K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 288$260.49 / share | $75.02K | Jul 27Filed Jul 29 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 191$254.07 / share | $48.53K | Jul 28Filed Jul 29 · 1d later | SEC filing |
| EXECUTIVE CHAIRMAN | Common StockSale10b5-1 | 1,718$260.49 / share | $447.52K | Jul 27Filed Jul 29 · 2d later | SEC filing |
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-1 | 884$260.49 / share | $230.27K | Jul 27Filed Jul 29 · 2d later | SEC filing |
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-1 | 1,003$254.07 / share | $254.83K | Jul 28Filed Jul 29 · 1d later | SEC filing |
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-1 | 1,010$260.49 / share | $263.1K | Jul 27Filed Jul 29 · 2d later | SEC filing |
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-1 | 1,204$254.07 / share | $305.9K | Jul 28Filed Jul 29 · 1d later | SEC filing |
| PRESIDENT, CHIEF BUS. OFFICER | Common StockSale10b5-1 | 782$260.49 / share | $203.7K | Jul 27Filed Jul 29 · 2d later | SEC filing |
| PRESIDENT, CHIEF BUS. OFFICER | Common StockSale10b5-1 | 931$254.07 / share | $236.54K | Jul 28Filed Jul 29 · 1d later | SEC filing |
| CEO AND PRESIDENT | Common StockSale10b5-1 | 2,190$260.49 / share | $570.47K | Jul 27Filed Jul 29 · 2d later | SEC filing |
| CEO AND PRESIDENT | Common StockSale10b5-1 | 3,580$254.07 / share | $909.57K | Jul 28Filed Jul 29 · 1d later | SEC filing |
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 782$260.49 / share | $203.7K | Jul 27Filed Jul 29 · 2d later | SEC filing |
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-13 trades | 2,419avg $253.96 / share | $614.34K | Jul 28Filed Jul 29 · 1d later | 3 filings
|
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 1,863$249.38 / share | $464.59K | Jul 29Filed Jul 29 · 0d later | SEC filing |
| Director | Common StockSale10b5-18 trades | 1,500avg $273.88 / share | $410.83K | Jul 15Filed Jul 17 · 2d later | 8 filings
|
| Director | Common StockSale10b5-1 | 135$274.82 / share | $37.1K | Jul 15Filed Jul 17 · 2d later | SEC filing |
| Director | Common StockSale10b5-16 trades | 3,150avg $265.68 / share | $836.9K | Jul 13Filed Jul 15 · 2d later | 6 filings
|
| EXECUTIVE CHAIRMAN | Common StockSale10b5-1 | 1,000$280.00 / share | $280K | Jul 6Filed Jul 8 · 2d later | SEC filing |
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-112 trades | 16,800avg $272.29 / share | $4.57M | Jul 1Filed Jul 6 · 5d later | 12 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-13 trades | 3,000avg $272.90 / share | $818.71K | Jul 1Filed Jul 6 · 5d later | 3 filings
|
| Director | Common StockGrant or award | 75Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,571Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 106Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,571Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 98Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,905Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,571Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 103Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,571Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 120Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,571Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 75Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,571Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| Director | Common StockGrant or award | 75Price not reported | Unavailable | Jun 26Filed Jun 30 · 4d later | SEC filing |
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-14 trades | 33,600avg $251.65 / share | $8.46M | Jun 24Filed Jun 26 · 2d later | 4 filings
|
| Director | Common StockSale10b5-1 | 16,530$250.00 / share | $4.13M | Jun 24Filed Jun 26 · 2d later | SEC filing |
| Director | Common StockSale10b5-19 trades | 1,500avg $219.87 / share | $329.81K | Jun 17Filed Jun 22 · 5d later | 9 filings
|
| Director | Common StockSale10b5-1 | 2,964$216.78 / share | $642.54K | Jun 16Filed Jun 17 · 1d later | SEC filing |
| Director | Common StockSale10b5-14 trades | 3,150avg $211.14 / share | $665.09K | Jun 15Filed Jun 17 · 2d later | 4 filings
|
| EXECUTIVE CHAIRMAN | Common StockSale10b5-111 trades | 50,000avg $214.03 / share | $10.7M | Jun 12Filed Jun 16 · 4d later | 11 filings
|
| EXECUTIVE CHAIRMAN | Common StockSale10b5-110 trades | 50,000avg $214.91 / share | $10.75M | Jun 15Filed Jun 16 · 1d later | 10 filings
|
| Director | Common StockOption exercise or conversion | 11,000$22.83 / share | $251.13K | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Common StockSale4 trades | 11,000avg $217.21 / share | $2.39M | Jun 5Filed Jun 9 · 4d later | 4 filings
|
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units11,000$22.83 exercise / conversion price | Not a separate purchase | Jun 5Filed Jun 9 · 4d later | SEC filing |
| CEO AND PRESIDENT | Common StockSale10b5-114 trades | 41,124avg $221.03 / share | $9.09M | Jun 4Filed Jun 5 · 1d later | 14 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-14 trades | 3,000avg $218.43 / share | $655.29K | Jun 1Filed Jun 3 · 2d later | 4 filings
|
| Director | Common StockGrant or award | 2,124Price not reported | Unavailable | May 29Filed Jun 3 · 5d later | SEC filing |
| Director | Common StockSale6 trades | 78,000avg $220.31 / share | $17.18M | Jun 1Filed Jun 3 · 2d later | 6 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-1 | 1,652$202.84 / share | $335.09K | May 26Filed May 28 · 2d later | SEC filing |
| PRESIDENT, CHIEF BUS. OFFICER | Common StockSale10b5-1 | 1,438$202.84 / share | $291.68K | May 26Filed May 28 · 2d later | SEC filing |
| Director | Common StockSale10b5-15 trades | 3,150avg $208.60 / share | $657.1K | May 8Filed May 15 · 7d later | 5 filings
|
| Director | Common StockSale10b5-18 trades | 1,500avg $201.56 / share | $302.35K | May 13Filed May 15 · 2d later | 8 filings
|
| EXECUTIVE CHAIRMAN | Common StockSale10b5-1 | 722$206.16 / share | $148.85K | May 4Filed May 6 · 2d later | SEC filing |
| EXECUTIVE CHAIRMAN | Common StockSale10b5-13 trades | 6,038avg $215.11 / share | $1.3M | May 5Filed May 6 · 1d later | 3 filings
|
| EXECUTIVE CHAIRMAN | Common StockGrant or award10b5-1 | 2,389Price not reported | Unavailable | May 5Filed May 6 · 1d later | SEC filing |
| EXECUTIVE CHAIRMAN | Common StockSale10b5-1 | 948$205.22 / share | $194.55K | May 5Filed May 6 · 1d later | SEC filing |
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 313$206.16 / share | $64.53K | May 1Filed May 5 · 4d later | SEC filing |
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-1 | 482$210.49 / share | $101.46K | May 4Filed May 5 · 1d later | SEC filing |
| Director | Common StockSale10b5-1 | 107$206.16 / share | $22.06K | May 1Filed May 5 · 4d later | SEC filing |
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-17 trades | 3,405avg $203.69 / share | $693.56K | May 1Filed May 5 · 4d later | 7 filings
|
| PRESIDENT, CHIEF BUS. OFFICER | Common StockSale10b5-1 | 291$206.16 / share | $59.99K | May 1Filed May 5 · 4d later | SEC filing |
| CEO AND PRESIDENT | Common StockSale10b5-1 | 902$206.16 / share | $185.96K | May 1Filed May 5 · 4d later | SEC filing |
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-1 | 330$206.16 / share | $68.03K | May 1Filed May 5 · 4d later | SEC filing |
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-12 trades | 1,993avg $204.14 / share | $406.86K | Apr 27Filed Apr 29 · 2d later | 2 filings
|
| CHIEF FINANCIAL OFFICER | Common StockSale10b5-15 trades | 3,070avg $193.74 / share | $594.79K | Apr 29Filed Apr 29 · 0d later | 5 filings
|
| CEO AND PRESIDENT | Common StockSale10b5-12 trades | 5,838avg $204.14 / share | $1.19M | Apr 27Filed Apr 29 · 2d later | 2 filings
|
| PRESIDENT, CHIEF BUS. OFFICER | Common StockSale10b5-12 trades | 1,688avg $204.10 / share | $344.52K | Apr 27Filed Apr 29 · 2d later | 2 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-12 trades | 2,182avg $204.10 / share | $445.34K | Apr 27Filed Apr 29 · 2d later | 2 filings
|
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-12 trades | 1,861avg $204.09 / share | $379.81K | Apr 27Filed Apr 29 · 2d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 473avg $204.00 / share | $96.49K | Apr 27Filed Apr 29 · 2d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 3,071avg $196.42 / share | $603.2K | Apr 29Filed Apr 29 · 0d later | 2 filings
|
| Director | Common StockGrant or award | 117Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 222Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 108Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 222Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 114Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 222Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 132Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 222Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 5Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 86Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 83Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockGrant or award | 83Price not reported | Unavailable | Apr 24Filed Apr 28 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 1,500avg $199.63 / share | $299.44K | Apr 17Filed Apr 21 · 4d later | 2 filings
|
| EXECUTIVE CHAIRMAN | Common StockOption exercise or conversion | 58,292$9.59 / share | $559.02K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| EXECUTIVE CHAIRMAN | Common StockExercise-price or tax withholding | 27,610$204.87 / share | $5.66M | Apr 6Filed Apr 8 · 2d later | SEC filing |
| EXECUTIVE CHAIRMAN | Stock Option (right to buy)Option exercise or conversion | Derivative units58,292$9.59 exercise / conversion price | Not a separate purchase | Apr 6Filed Apr 8 · 2d later | SEC filing |
| SEC. AND CHIEF LEGAL OFFICER | Common StockSale10b5-15 trades | 8,400avg $203.31 / share | $1.71M | Apr 1Filed Apr 3 · 2d later | 5 filings
|
| PRESIDENT, CLINICALDIAGNOSTICS | Common StockSale10b5-13 trades | 3,000avg $202.30 / share | $606.9K | Apr 1Filed Apr 3 · 2d later | 3 filings
|
| EXECUTIVE CHAIRMAN | Common StockOption exercise or conversion | 41,708$9.59 / share | $399.98K | Mar 31Filed Apr 1 · 1d later | SEC filing |
| EXECUTIVE CHAIRMAN | Stock Option (right to buy)Option exercise or conversion | Derivative units41,708$9.59 exercise / conversion price | Not a separate purchase | Mar 31Filed Apr 1 · 1d later | SEC filing |
Natera, Inc. - Common Stock (NTRA) · Stock
The filing reports a purchase for a joint account.
Josh GottheimerReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.